Which has grown faster, OMCL or SNDX?

Over the past five years, SNDX grew revenue faster — OMCL at a 4.77% CAGR versus SNDX at 178.06%.

Is OMCL or SNDX more profitable?

OMCL runs the higher net margin — OMCL at 3.13% versus SNDX at -87.60%.

How have OMCL and SNDX total returns compared?

Over the past 10 years, OMCL delivered -0.80% and SNDX delivered 1.04% annualized total return. Past performance doesn't predict future results.

Omnicell, Inc. (OMCL) vs Syndax Pharmaceuticals, Inc. (SNDX)

A side-by-side comparison of Omnicell, Inc. and Syndax Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

OMCL

Omnicell, Inc.

$1.61B

$35.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SNDX

Syndax Pharmaceuticals, Inc.

$1.54B

$17.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — OMCL vs SNDX

growth of $100 · dividends reinvested · last 10y

OMCL -7.5% (-0.8%/yr)SNDX +17.3% (+1.6%/yr)SNDX compounded faster over this window

OMCL SNDX

OMCL vs SNDX: by the numbers

•OMCL is the larger company ($1.61B vs $1.54B market cap).
•OMCL is profitable (3.13% net margin) while SNDX runs a net loss (-87.60%).
•SNDX grew revenue faster over the past five years (178.06% vs 4.77% CAGR).

Metrics side by side

Valuation

Metric	OMCL	SNDX
P/E ratio	41.97	N/A
Forward P/E	15.63	N/A
P/S ratio	1.29	6.11
P/B ratio	1.25	101.94
EV / EBITDA	10.75	N/A
FCF yield	8.77%	N/A

Profitability

Metric	OMCL	SNDX
Gross margin	44.77%	97.47%
Operating margin	4.73%	-158.45%
Net margin	3.13%	-87.60%
ROE	3.03%	-1462.12%
ROIC	2.43%	-32.15%

Growth (annualized)

Metric	OMCL	SNDX
Revenue CAGR (5Y)	4.77%	178.06%
EPS CAGR (5Y)	-43.29%	N/A
FCF CAGR (5Y)	-8.10%	N/A
Total return CAGR (5Y)	-26.44%	-0.01%

Frequently asked

Which has grown faster, OMCL or SNDX?: Over the past five years, SNDX grew revenue faster — OMCL at a 4.77% CAGR versus SNDX at 178.06%.
Is OMCL or SNDX more profitable?: OMCL runs the higher net margin — OMCL at 3.13% versus SNDX at -87.60%.
How have OMCL and SNDX total returns compared?: Over the past 10 years, OMCL delivered -0.80% and SNDX delivered 1.04% annualized total return. Past performance doesn't predict future results.

Go deeper

Full OMCL analysis Full SNDX analysis Interactive comparison tool

Dig into the metrics

Omnicell P/E ratio Omnicell ROE Syndax Pharmaceuticals ROE Omnicell operating margin Syndax Pharmaceuticals operating margin Omnicell revenue growth Syndax Pharmaceuticals revenue growth Omnicell free cash flow Syndax Pharmaceuticals free cash flow

Omnicell & Syndax Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.